Telegram RegisterThe public register of Telegram
Telegram profile photo for The MD Briefing | Global Medical Updates

Channel

The MD Briefing | Global Medical Updates

@TheMDBriefing

2 usernames

On this record: Topic · Growth · Engagement · Reactions · Posts · Citations · Telegram's recommendations · Cite this entry

2,928subscribers

+468 since we began measuring on 7 August 2026

Risers and fallers across the register · movement among entries of 1,000–3,162.

Register entry

Telegram ID-1002069907188
TypeChannel
Usernames@medscape24 @TheMDBriefing
CreatedBetween 1 November 2023 and 31 May 2024 — estimated from Telegram’s id allocation, not measured. How this range is calculated.
First recorded7 August 2026
Last confirmed live15 November 2026
Measurements held28
Confirmed unchanged1 time, most recently 15 November 2026
On Telegramt.me/TheMDBriefing

Topic

Health & wellness — a classification, not a measurement. An on-box language model (Qwen3.6-35B-A3B-FP8, prompt version 1) read this channel’s own recent posts on 15 September 2026 and assigned it the closest of 31 fixed categories, at 93% confidence. This is a model’s judgement about what the channel is likely to be about, not a fact this register measured the way a subscriber count or a view count is measured — it can be revised on a later pass, and it carries no weight anywhere else on this page. How this classification works, and the other topics.

Growth

2,4602,9282,6947 August 2026 — 2,460 subscribers7 August 2026 — 2,460 subscribers8 August 2026 — 2,463 subscribers11 August 2026 — 2,466 subscribers15 August 2026 — 2,474 subscribers18 August 2026 — 2,484 subscribers21 August 2026 — 2,491 subscribers24 August 2026 — 2,508 subscribers28 August 2026 — 2,517 subscribers31 August 2026 — 2,527 subscribers2 September 2026 — 2,537 subscribers8 September 2026 — 2,566 subscribers12 September 2026 — 2,631 subscribers15 September 2026 — 2,665 subscribers30 September 2026 — 2,786 subscribers7 October 2026 — 2,827 subscribers13 October 2026 — 2,857 subscribers16 October 2026 — 2,868 subscribers19 October 2026 — 2,879 subscribers22 October 2026 — 2,883 subscribers26 October 2026 — 2,891 subscribers29 October 2026 — 2,896 subscribers1 November 2026 — 2,901 subscribers4 November 2026 — 2,908 subscribers7 November 2026 — 2,927 subscribers10 November 2026 — 2,926 subscribers12 November 2026 — 2,921 subscribers15 November 2026 — 2,928 subscribers7 August 202615 November 2026
28 measurements spanning 100 days, net +468. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 2,390–2,998 and does not start at zero.
Measurement log — every subscribers count we have recorded, most recent 20 of 28
Measured (UTC)SubscribersChange
15 Nov 2026, 19:582,928+7
12 Nov 2026, 19:222,921-5
10 Nov 2026, 13:392,926-1
7 Nov 2026, 09:502,927+19
4 Nov 2026, 05:472,908+7
1 Nov 2026, 11:452,901+5
29 Oct 2026, 12:042,896+5
26 Oct 2026, 01:212,891+8
22 Oct 2026, 21:512,883+4
19 Oct 2026, 13:002,879+11
16 Oct 2026, 15:172,868+11
13 Oct 2026, 17:502,857+30
7 Oct 2026, 18:402,827+41
30 Sept 2026, 17:212,786+121
15 Sept 2026, 22:192,665+34
12 Sept 2026, 11:372,631+65
8 Sept 2026, 10:382,566+29
2 Sept 2026, 23:572,537+10
31 Aug 2026, 04:372,527+10
28 Aug 2026, 00:042,517first reading

Engagement

40 posts held, back to 7 August 2026 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 2 pages of Telegram’s post history, 20 posts per page.

ERR · 30 days
6.16%
avg views ÷ 2,928 subscribers
Avg views / post
180
18 posts measured
Reaction rate
0.159%
reactions ÷ views · ER floor
Posts in window
20
of 40 held

ERR is average views per post over the last 30 days divided by subscribers, the definition TGStat uses, so this figure is comparable with the one you will see elsewhere. It falls structurally as a channel grows: a high ERR on a small channel and a low one on a large channel describe reach mathematics, not quality. We publish the figure and the sample it came from and pass no verdict on it.

ER is defined industry-wide as (forwards + reactions + comments) ÷ views — note the denominator is views, not subscribers. Telegram’s public web preview carries views and reactions but not forward or comment counts, so the reaction rate above is the reactions term only and is therefore a floor: the true ER for this channel is higher by an amount we have not measured and will not estimate. It is computed over the 1 of 18 measured posts that carry a reaction reading, and over those same posts' views.

What these figures were computed from
WindowRolling 30 days · latest post in window 12 November 2026
Posts held40 (7 August 2026 – 12 November 2026)
Views total3,244
Reactions total2
Forwards / commentsnot exposed by the public surface — not measured, not estimated
Readings taken12 Nov 2026, 19:22 UTC

Views are a single reading per post, taken at the time above. A post published in the last day or two is still accumulating views, which pulls the 30-day average down slightly. That is a property of the standard definition rather than a fault in it, so we keep the definition rather than “correcting” the number into something nobody can reproduce.

Precision. Telegram publishes view counts on its public widget in short form — 8.12K, 3.7M — so any reading at or above 1,000 reaches us rounded to three significant figures, and only counts below 1,000 are exact. Averages and rates derived from them are shown to the same precision rather than to the unit: a figure like 3,701,250 would assert digits nobody measured.

Reaction counts are published per emoji and rounded the same way, so a total below 1,000 is exact and a larger one is a sum that may carry a rounded component from each emoji above 1,000. Because it is a sum, it does not look rounded — read a large reaction total as three significant figures per contributing emoji rather than as the figure it prints.

Reaction mix

2 reactions across 1 post, in 1 kind.

Every reaction kind recorded on the sample, most used first
ReactionCountShareShare, drawn
❤2100.0%

No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.

Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.

Coverage. Reactions were read on 1 of the 40 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 2 reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.

Measured over the 40 most recent posts we hold, published 7 August 2026 to 12 November 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.

Recent posts

Telegram’s own ‘edited’ marker: 0 of 20 posts held from the last 30 days (0%) carried it when this register last read them. The marker says a post was changed after publishing, not what it said before — this register holds the earlier wording only where an edit fell between two of its own reads (see the edit ledger and how it is measured).

12 Nov 2026, 19:01 UTC10 viewsread 12 November 2026

Infectious Diseases & Preventive Medicine ​💉 GUIDELINE UPDATE | Infectious Diseases & Primary Care ACIP Lowers Routine Adult Pneumococcal Vaccination Age from 65 to 50 Years ​🔹 The Update: Updated CDC Advisory Committee on Immunization Practices (ACIP) guidelines now formally recommend a single dose of a pneumococcal conjugate vaccine (PCV21 [Capvaxive] or PCV20 [Prevnar 20]) for all PCV-naive adults aged 50 years an…

12 Nov 2026, 17:01 UTC45 viewsread 12 November 2026

Nephrology ​🫘 LANDMARK TRIAL | Nephrology & Glomerular Disease Pegcetacoplan Slashes Proteinuria by 68% in C3 Glomerulopathy (VALIANT Trial) ​🔹 The Update: Phase III VALIANT trial data showed that systemic C3/C3b complement inhibition with Pegcetacoplan achieved a statistically significant 68.3% reduction in proteinuria (UPCR) at Week 26 compared to placebo, alongside eGFR stabilization across both native and post-tr…

12 Nov 2026, 15:03 UTC66 viewsread 12 November 2026

Pulmonology & Critical Care ​🫁 PHASE III BREAKTHROUGH | Pulmonology Nerandomilast Slows Lung Function Decline in Progressive Pulmonary Fibrosis (FIBRONEER) ​🔹 The Update: Top-line Phase III results from the FIBRONEER program confirmed that Nerandomilast (BI 1015550), an oral preferential phosphodiesterase 4B (PDE4B) inhibitor, met its primary endpoint by significantly reducing the absolute decline in forced vital cap…

12 Nov 2026, 13:01 UTC82 viewsread 12 November 2026

Hematology & Oncology ​🎗️ FDA APPROVAL | Hematology & Oncology First-in-Class Menin Inhibitor Revumenib Approved for KMT2A-Rearranged Acute Leukemia ​🔹 The Update: The FDA approved Revumenib (Revuforj), a selective first-in-class menin inhibitor, for adult and pediatric patients (≥1 year) with relapsed or refractory acute leukemia harboring a KMT2A (MLL) translocation, based on the AUGMENT-101 trial showing a 21.2% C…

12 Nov 2026, 11:04 UTC88 viewsread 12 November 2026

Cardiac Electrophysiology ​⚡ CLINICAL TRIAL | Cardiac Electrophysiology LAA Closure Beats Oral Anticoagulation for Bleeding Risk Post-AF Ablation (OPTION Trial) ​🔹 The Update: The OPTION trial (n = 1,600) demonstrated that Left Atrial Appendage Closure (LAAC with Watchman FLX) following catheter ablation for atrial fibrillation resulted in significantly lower non-procedural major or clinically relevant non-major blee…

12 Nov 2026, 09:00 UTC91 viewsread 12 November 2026

Neuro-Oncology (SNO 2026) ​🧠 CONGRESS SPOTLIGHT | Neuro-Oncology (SNO 2026) Vorasidenib Real-World Integration & Seizure Control in IDH-Mutant Grade 2 Glioma ​🔹 The Update: As the Society for Neuro-Oncology (SNO 2026) annual meeting kicks off today, extended subgroup analyses from the INDIGO trial highlight that the dual IDH1/2 inhibitor Vorasidenib (Voranigo) not only prolongs progression-free survival and time-to-n…

12 Nov 2026, 07:00 UTC98 viewsread 12 November 2026

Hypertension & Diabetes ​🩸 PRACTICE-CHANGING TRIAL | Preventive Cardiology & Endocrinology Intensive Systolic BP Target (<120 mmHg) Slashes CV Events in Type 2 Diabetes (BPROAD) ​🔹 The Update: The BPROAD randomized trial (n = 12,821) published in NEJM revealed that targeting an intensive systolic blood pressure of <120 mmHg compared to standard treatment (<140 mmHg) in patients with Type 2 diabetes reduced major adve…

12 Nov 2026, 05:01 UTC94 viewsread 12 November 2026

Cardiology & Heart Failure ​🫀 LANDMARK TRIAL | Cardiology & Heart Failure Tirzepatide Cuts Heart Failure Events by 38% in HFpEF with Obesity (SUMMIT Trial) ​🔹 The Update: Late-breaking data from the Phase III SUMMIT trial published in NEJM demonstrated that dual GIP/GLP-1 receptor agonist Tirzepatide reduced the composite primary endpoint of cardiovascular death or worsening heart failure events by 38% compared to pl…

11 Nov 2026, 19:00 UTC118 viewsread 12 November 2026

Reproductive Medicine (OB/GYN) ​🤰 CLINICAL TRIAL | OB/GYN & Reproductive Medicine First-Line IVF Outperforms IUI in Unexplained Infertility ​🔹 The Update: Randomized clinical trial data demonstrated that immediate first-line In Vitro Fertilization (IVF) achieved significantly higher live birth rates within 7 months compared to Intrauterine Insemination (IUI) in couples with unexplained infertility. ​🎯 Bedside Takeawa…

11 Nov 2026, 18:04 UTC121 viewsread 12 November 2026

Hepatology ​🧬 GUIDELINE SHIFT | Hepatology ALP Normalization as the New PBC Standard & High MASH Drug Persistence ​🔹 The Update: Phase III data for Elafibranor and Seladelpar solidified complete Alkaline Phosphatase (ALP) Normalization as a primary therapeutic target in Primary Biliary Cholangitis (PBC), while real-world data confirmed high patient adherence to Resmetirom in MASH. ​🎯 Bedside Takeaway: Shift PBC manag…

11 Nov 2026, 17:04 UTC121 viewsread 12 November 2026

Preventive Cardiology ​🩺 VASCULAR IMAGING | Preventive Cardiology "Silent Atherosclerosis" Found in 57% of Adults—and 1 in 13 Under Age 30 ​🔹 The Update: A large European imaging cohort (n = 16,808) utilizing 3D vascular ultrasound and coronary CTA detected subclinical atherosclerosis in 57.1% of asymptomatic participants overall, including 7.7% of adults under age 30. ​🎯 Bedside Takeaway: Men developed atherosclerot…

11 Nov 2026, 16:01 UTC244 viewsread 12 November 2026

Neuro-Oncology ​🔬 CONGRESS PREVIEW | Neuro-Oncology (SNO 2026) Targeted Advances in H3 K27M Gliomas & Recurrent Meningiomas ​🔹 The Update: Ahead of the Society for Neuro-Oncology (SNO 2026) annual meeting, focus centers on Phase III ACTION trial updates for Dordaviprone (Modeyso) in H3 K27M-mutant diffuse gliomas and the Phase II launch of JZP3507 (ONC206) in recurrent Grade II/III meningiomas. ​🎯 Bedside Takeaway: D…

Showing the 12 most recent of 40 posts we hold for @TheMDBriefing. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Forward network

Republished by

Channels on the register that have forwarded this channel's posts into their own feed.

Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.

Mentions

Named by 2 registered channels — every channel on the register whose own posts have named this one, by its current username or any other username it currently holds, merged from two separately captured readings of the same fact so a namer caught by only one of them is not missed and a namer both caught is not counted twice. A username this channel has since dropped is not matched — that handle may belong to someone else now, and crediting today’s namer to yesterday’s owner would misattribute it.

Named by

Channels on the register whose posts name this channel's handle.

A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.

Appears in Telegram’s recommendations for other channels

The reverse of the list above, and a different kind of signal. This does not require this channel to have ever been asked about directly — each row below is a channel we DID ask Telegram about, whose Telegram-generated list happened to include this one. A channel can appear here with an empty list above it, because being named by someone else’s query is independent of having been queried itself.

Medical Mnemonics
@medical_mnemonics · 65,026
Telegram ranks this channel #3 of 70 here — alongside 69 others — read 26 August 2026
NCLEX-RNpreparation
@NclexRNPrepration · 35,072
Telegram ranks this channel #9 of 61 here — alongside 60 others — read 9 September 2026
Pharmacology
@pharma_vid · 66,723
Telegram ranks this channel #13 of 69 here — alongside 68 others — read 26 August 2026
Medical Books
@MedicalBooksStoreA · 44,018
Telegram ranks this channel #18 of 67 here — alongside 66 others — read 29 August 2026
PSM by Kashish Grover (Channel)
@kayspsm · 42,226
Telegram ranks this channel #23 of 63 here — alongside 62 others — read 28 August 2026
Osmosis
@osmosis_mogahed772 · 68,582
Telegram ranks this channel #23 of 75 here — alongside 74 others — read 26 August 2026
مكتبه التمريض | NURSING LIBRARY
@nurse_library · 19,942
Telegram ranks this channel #29 of 73 here — alongside 72 others — read 1 October 2026
Psychiatry
@psychiatry_vid · 23,203
Telegram ranks this channel #30 of 72 here — alongside 71 others — read 19 September 2026
𝗙𝗿𝗲𝗲 𝗦𝘂𝗿𝗴𝗲𝗿𝘆 𝗕
@freesurgerybooks28 · 38,717
Telegram ranks this channel #31 of 68 here — alongside 67 others — read 19 September 2026
Medical Guidelines 2025_2026
@Mmmmmm221234 · 37,572
Telegram ranks this channel #37 of 66 here — alongside 65 others — read 2 September 2026
PDFology
@PDFology · 65,615
Telegram ranks this channel #40 of 77 here — alongside 76 others — read 20 August 2026
📚المكتبة الطبية في عالم الطب 📚
@BooksMed · 28,076
Telegram ranks this channel #41 of 67 here — alongside 66 others — read 10 September 2026
Osmosis
@JustOsmosis · 59,513
Telegram ranks this channel #41 of 80 here — alongside 79 others — read 26 August 2026
REET RAS Prelims Mains Exam™
@REET_RAS_prelims_mains_Exam · 122,496
Telegram ranks this channel #45 of 75 here — alongside 74 others — read 13 August 2026
Mukhmohit’s PSM Simplified
@mukhmohitPSM_channel · 19,117
Telegram ranks this channel #49 of 71 here — alongside 70 others — read 4 October 2026
BAMS UG & PG Notes ( Ayurveda+ Modern) #AIAPGET , BAMS Exit Test ( NExT)
@AyurvedStudyHub · 23,818
Telegram ranks this channel #49 of 83 here — alongside 82 others — read 19 September 2026
AyurGuide by Dr. Ajit Patil
@ayurguideajitpatil · 40,551
Telegram ranks this channel #54 of 65 here — alongside 64 others — read 30 August 2026
Nursing books مكتبه التمريض
@getnursingbooks · 25,405
Telegram ranks this channel #56 of 66 here — alongside 65 others — read 17 September 2026
رابطة المراكز الطبية
@Medical_Centers_Association · 25,638
Telegram ranks this channel #57 of 73 here — alongside 72 others — read 12 September 2026
Medical History🔍🩺
@hist_first · 21,951
Telegram ranks this channel #58 of 75 here — alongside 74 others — read 25 September 2026
Urology Books, Guidelines & Videos
@UroResources · 21,458
Telegram ranks this channel #58 of 69 here — alongside 68 others — read 24 September 2026
Boards and Beyond 2024
@Boards_Beyond_videos · 43,223
Telegram ranks this channel #62 of 76 here — alongside 75 others — read 30 August 2026
UGC-NET/JRF
@UGCNET_JRF_NTA · 40,822
Telegram ranks this channel #62 of 72 here — alongside 71 others — read 29 August 2026
General Physical Examination
@Physical_Examinationn · 21,250
Telegram ranks this channel #63 of 79 here — alongside 78 others — read 24 September 2026

This channel appears in 31 seed channels' Telegram-generated recommendation lists in total, of which the 24 where it ranks highest are shown above. Each is Telegram’s list for THAT channel, not this one — see how this is measured.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 15 November 2026 — this entry's latest reading, not the date you are reading this.

“The MD Briefing | Global Medical Updates” (@TheMDBriefing), 2,928 subscribers as measured 15 November 2026. Telegram Register, tgregister.com/channel/TheMDBriefing.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.